Asian lung cancer trial tests which drug better slows disease
NCT ID NCT02838420
Summary
This study compares two oral medications, alectinib and crizotinib, for Asian patients with a specific type of advanced lung cancer (ALK-positive). The goal is to see which drug is more effective at delaying cancer progression and is better tolerated. Participants who have not received prior treatment for their advanced cancer take one of the two drugs twice daily.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC LYMPHOMA KINASE-POSITIVE NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Beijing Cancer Hospital
Beijing, 100142, China
-
Beijing Chest Hospital
Beijing, 101149, China
-
Fudan University Shanghai Cancer Center
Shanghai, 200032, China
-
Guangdong General Hospital
Guangzhou, 510080, China
-
Harbin Medical University Cancer Hospital
Harbin, 150081, China
-
Jiangsu Cancer Hospital
Nanjing, 210009, China
-
Jilin Cancer Hospital
Changchun, 132013, China
-
Kangbuk Samsung Hospital
Seoul, 03181, South Korea
-
Rajavithi Hospital
Bangkok, 10400, Thailand
-
Ramathibodi Hospital
Bangkok, 10400, Thailand
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Shanghai Pulmonary Hospital
Shanghai, 200433, China
-
Shanghai chest hospital
Shanghai, 200030, China
-
Songklanagarind Hospital
Songkhla, 90110, Thailand
-
Sun Yet-sen University Cancer Center
Guangzhou, 510060, China
-
The First Affiliated Hospital of College of Medicine, Zhejiang University
Hangzhou, 310003, China
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, 510120, China
-
West China Hospital, Sichuan University
Chengdu, 610041, China
-
Zhejiang Cancer Hospital
Hangzhou, 310022, China
-
the First Hospital of Jilin University
Changchun, 130021, China
Conditions
Explore the condition pages connected to this study.